Literature DB >> 23636457

NLRP3 deletion protects from hyperoxia-induced acute lung injury.

Jutaro Fukumoto1, Itsuko Fukumoto, Prasanna Tamarapu Parthasarathy, Ruan Cox, Bao Huynh, Gurukumar Kollongod Ramanathan, Rajan Babu Venugopal, Diane S Allen-Gipson, Richard F Lockey, Narasaiah Kolliputi.   

Abstract

Inspiration of a high concentration of oxygen, a therapy for acute lung injury (ALI), could unexpectedly lead to reactive oxygen species (ROS) production and hyperoxia-induced acute lung injury (HALI). Nucleotide-binding domain and leucine-rich repeat PYD-containing protein 3 (NLRP3) senses the ROS, triggering inflammasome activation and interleukin-1β (IL-1β) production and secretion. However, the role of NLRP3 inflammasome in HALI is unclear. The main aim of this study is to determine the effect of NLRP3 gene deletion on inflammatory response and lung epithelial cell death. Wild-type (WT) and NLRP3(-/-) mice were exposed to 100% O2 for 48-72 h. Bronchoalveolar lavage fluid and lung tissues were examined for proinflammatory cytokine production and lung inflammation. Hyperoxia-induced lung pathological score was suppressed in NLRP3(-/-) mice compared with WT mice. Hyperoxia-induced recruitment of inflammatory cells and elevation of IL-1β, TNFα, macrophage inflammatory protein-2, and monocyte chemoattractant protein-1 were attenuated in NLRP3(-/-) mice. NLRP3 deletion decreased lung epithelial cell death and caspase-3 levels and a suppressed NF-κB levels compared with WT controls. Taken together, this research demonstrates for the first time that NLRP3-deficient mice have suppressed inflammatory response and blunted lung epithelial cell apoptosis to HALI.

Entities:  

Keywords:  hyperoxia; inflammation; injury; lung; reactive oxygen species

Mesh:

Substances:

Year:  2013        PMID: 23636457      PMCID: PMC3725631          DOI: 10.1152/ajpcell.00086.2013

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  51 in total

1.  Oxidant injury to the alveolar epithelium: biochemical and pharmacologic studies.

Authors:  B A Freeman; P C Panus; S Matalon; B J Buckley; R R Baker
Journal:  Res Rep Health Eff Inst       Date:  1993-01

2.  Interleukin-1 stimulates tumor necrosis factor-alpha (TNF-alpha) release from cytotrophoblastic BeWo cells independently of induction of the TNF-alpha mRNA.

Authors:  M Knöfler; H Kiss; B Mösl; C Egarter; P Husslein
Journal:  FEBS Lett       Date:  1997-03-24       Impact factor: 4.124

3.  IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells.

Authors:  A Sica; K Matsushima; J Van Damme; J M Wang; N Polentarutti; E Dejana; F Colotta; A Mantovani
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

4.  Effects of high oxygen exposure on bioenergetics in isolated type II pneumocytes.

Authors:  L M Simon; T A Raffin; W H Douglas; J Theodore; E D Robin
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-07

5.  Regulation of interleukin-8 gene expression by interleukin-1beta, osteotropic hormones, and protein kinase inhibitors in normal human bone marrow stromal cells.

Authors:  L R Chaudhary; L V Avioli
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

6.  Oxidant injury of lung parenchymal cells.

Authors:  W J Martin; J E Gadek; G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

7.  Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes.

Authors:  Y Jiang; D I Beller; G Frendl; D T Graves
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

8.  Interleukin-1 beta induction of tumor necrosis factor-alpha gene expression in human astroglioma cells.

Authors:  J R Bethea; I Y Chung; S M Sparacio; G Y Gillespie; E N Benveniste
Journal:  J Neuroimmunol       Date:  1992-02       Impact factor: 3.478

9.  Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats.

Authors:  H Schmal; T P Shanley; M L Jones; H P Friedl; P A Ward
Journal:  J Immunol       Date:  1996-03-01       Impact factor: 5.422

10.  Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality.

Authors:  E J Miller; A B Cohen; S Nagao; D Griffith; R J Maunder; T R Martin; J P Weiner-Kronish; M Sticherling; E Christophers; M A Matthay
Journal:  Am Rev Respir Dis       Date:  1992-08
View more
  73 in total

1.  Dexmedetomidine mitigates CLP-stimulated acute lung injury via restraining the RAGE pathway.

Authors:  Hongyi Hu; Dongsheng Shi; Chenlu Hu; Xiao Yuan; Juan Zhang; Huaqin Sun
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment.

Authors:  Ruan Cox; Oluwakemi Phillips; Jutaro Fukumoto; Itsuko Fukumoto; Prasanna Tamarapu Parthasarathy; Stephen Arias; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

3.  An old molecule with a new role: microtubules in inflammasome regulation.

Authors:  Prasanna Tamarapu Parthasarathy; Young Cho; Richard Lockey; Narasaiah Kolliputi
Journal:  Cell Biochem Biophys       Date:  2014-09       Impact factor: 2.194

4.  CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.

Authors:  Lei Jiang; Dongsheng Fei; Rui Gong; Wei Yang; Wei Yu; Shangha Pan; Mingran Zhao; Mingyan Zhao
Journal:  Inflamm Res       Date:  2016-07-13       Impact factor: 4.575

5.  Altered expression of p63 isoforms and expansion of p63- and club cell secretory protein-positive epithelial cells in the lung as novel features of aging.

Authors:  Jutaro Fukumoto; Sahebgowda Sidramagowda Patil; Sudarshan Krishnamurthy; Smita Saji; Irene John; Venkata Ramireddy Narala; Helena Hernández-Cuervo; Matthew Alleyn; Mason T Breitzig; Lakshmi Galam; Ramani Soundararajan; Uddhav K Chaudhari; Barbara C Hansen; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Cell Physiol       Date:  2019-01-16       Impact factor: 4.249

6.  Endothelial PINK1 mediates the protective effects of NLRP3 deficiency during lethal oxidant injury.

Authors:  Yi Zhang; Maor Sauler; Amanda S Shinn; Huan Gong; Maria Haslip; Peiying Shan; Praveen Mannam; Patty J Lee
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

7.  Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice.

Authors:  Yong Zhou; Tian Liu; Jia-Xi Duan; Ping Li; Guo-Ying Sun; Yong-Ping Liu; Jun Zhang; Liang Dong; Kin Sing Stephen Lee; Bruce D Hammock; Jian-Xin Jiang; Cha-Xiang Guan
Journal:  Shock       Date:  2017-05       Impact factor: 3.454

8.  The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia.

Authors:  Jie Liao; Vishal S Kapadia; L Steven Brown; Naeun Cheong; Christopher Longoria; Dan Mija; Mrithyunjay Ramgopal; Julie Mirpuri; Donald C McCurnin; Rashmin C Savani
Journal:  Nat Commun       Date:  2015-11-27       Impact factor: 14.919

9.  Isoflurane attenuates lipopolysaccharide-induced acute lung injury by inhibiting ROS-mediated NLRP3 inflammasome activation.

Authors:  Ning Yin; Zhendan Peng; Bin Li; Jiangyan Xia; Zhen Wang; Jing Yuan; Lei Fang; Xinjiang Lu
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

10.  Deletion of P2X7 attenuates hyperoxia-induced acute lung injury via inflammasome suppression.

Authors:  Lakshmi Galam; Ashna Rajan; Athena Failla; Ramani Soundararajan; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.